| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/25/1992 | CA2100681A1 Monoclonal antibodies to elam-1 and their uses |
| 07/24/1992 | CA2058464A1 Induction of tolerance with modified immunogens |
| 07/23/1992 | WO1992012721A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/23/1992 | WO1992011872A1 Mitotoxin for treatment of vascular injury |
| 07/23/1992 | WO1992011871A1 Stable suspension formulations for controlled delivery of pharmaceutical compounds |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/23/1992 | WO1992011842A1 Liposomal-polyene preliposomal powder and method for its preparation |
| 07/23/1992 | DE4101394A1 Verfahren zum koppeln von kohlenhydraten an traeger, insbesondere proteine A method for coupling of carbohydrates to traeger, especially proteins |
| 07/23/1992 | CA2100252A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/22/1992 | EP0495421A1 Use of carrageenans in topical ophthalmic compositions |
| 07/22/1992 | EP0495376A2 Cell surface receptor complimentation |
| 07/22/1992 | EP0495265A1 Acid-labile linker molecules |
| 07/22/1992 | EP0495187A1 Protein nanomatrixes and method of production |
| 07/22/1992 | EP0495105A1 Inhibitor of absorption of digestion product of food and drink |
| 07/22/1992 | EP0494998A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 07/22/1992 | EP0494974A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 07/22/1992 | EP0494910A1 Eye-drops. |
| 07/22/1992 | EP0494904A1 Device for oral administration of an active principle for preventive treatment of caries in babies. |
| 07/22/1992 | EP0493441A4 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| 07/22/1992 | EP0481007A4 Slow release vehicles for minimizing skin irritancy of topical compositions |
| 07/22/1992 | EP0477289A4 Anhydrous oil-based liquid suspension for delivering a medicament |
| 07/21/1992 | CA1305419C Enhancers for the transdermal flux of certain 1,4-dihydropyridinederivatives |
| 07/21/1992 | CA1305418C Transdermal delivery of pharmaceuticals |
| 07/21/1992 | CA1305417C Stable formulations of ricin toxin a chain and of rta-immunoconjugates and stabilizer screening methods therefor |
| 07/21/1992 | CA1305415C Method of purifying toxin conjugates using hydrophobic interaction chromatography |
| 07/18/1992 | WO1992012722A1 Antifreeze glycopeptide compositions to protect cells and tissues during freezing |
| 07/15/1992 | EP0494244A1 Therapeutic ribozyme compositions and expression vectors |
| 07/15/1992 | EP0494175A1 Compositions for cell adhesion inhibition and methods of use |
| 07/15/1992 | EP0358709B1 Diabetic control by combined insulin forms |
| 07/15/1992 | EP0202298B1 Wound healing agents |
| 07/14/1992 | US5130479 Hydrolytically degradable hydrophilic gels and the method for preparation thereof using n,o-dimethacryloylhydroxylamine as a cross-linking agent |
| 07/14/1992 | US5130418 Method to stabilize basic fibroblast growth factor |
| 07/14/1992 | US5130412 Electrochemical drug release and article |
| 07/14/1992 | US5130305 Cyclophosphamide - sodium bicarbonate lyophilizates |
| 07/14/1992 | US5130298 Stabilized compositions containing epidermal growth factor |
| 07/14/1992 | US5130297 Polypeptides for treatment of arthritis and diabetes |
| 07/14/1992 | US5130244 Thrombin with disaccharides and arginine |
| 07/14/1992 | US5130139 Coadministering lysosomac uptake inhibiting agent |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130126 Polymer-drug conjugate and a method of producing it |
| 07/14/1992 | US5130124 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide |
| 07/14/1992 | CA1305059C Stabilized menadione bisulfite formulations and their preparation |
| 07/14/1992 | CA1305057C Calcium salts |
| 07/14/1992 | CA1305054C2 Encapsulation of antineoplastic agents in liposomes |
| 07/14/1992 | CA1305053C Synthetic polymeric drugs |
| 07/14/1992 | CA1305051C Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
| 07/09/1992 | WO1992011368A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/09/1992 | WO1992011039A1 Derivatized tris-catechol chelating agents |
| 07/09/1992 | WO1992011036A1 Adjuvants containing unsaturated lipid |
| 07/09/1992 | WO1992011031A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
| 07/09/1992 | WO1992010996A1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/09/1992 | WO1992010989A1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein |
| 07/08/1992 | WO1992011860A1 Topical formulation of cyclosporine |
| 07/08/1992 | EP0494057A1 Hydrolytic stabilizer for water soluble bis-quaternary pyridinium oximes |
| 07/08/1992 | EP0493496A1 Ibuprofen triturates and topical compositions containing same |
| 07/08/1992 | EP0493485A1 Erection-inducing methods and compositions |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0493441A1 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants. |
| 07/08/1992 | EP0493404A1 Topical antiinflammatory compositions with minimal systemic absorption |
| 07/08/1992 | CA2077647A1 Topical formulation of cyclosporine |
| 07/07/1992 | US5128376 Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
| 07/07/1992 | US5128373 Storage stability |
| 07/07/1992 | US5128332 Method of treating cardiovascular diseases using inositoltrisphosphate |
| 07/07/1992 | US5128326 Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/07/1992 | US5128249 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for oral pharmaceutical use |
| 07/07/1992 | US5128246 Olfactory, genetic engineering |
| 07/07/1992 | US5128151 Stabilized menadione bisulfite formulations and their preparation |
| 07/07/1992 | US5128144 Pressing having sustained release of active compound |
| 07/07/1992 | US5128142 Sustained release drug delivery system |
| 07/07/1992 | US5128138 Estradiol compositions and methods for topical application |
| 07/07/1992 | US5128135 Percutaneous or trans-mucosal absorption enhancers, preparations containing the enhancers, and a method of preparing thereof |
| 07/07/1992 | US5128132 Eriodictyon compositions and methods for treating internal mucous membranes |
| 07/07/1992 | US5128131 Process for preparing a watersoluble composition containing ginkgo leaf extracts |
| 07/07/1992 | US5128125 Dissolving polypyrrolidone in 2-pyrrolidone and heating; precipitation |
| 07/07/1992 | CA1304687C Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage |
| 07/04/1992 | WO1992011844A1 Stabilization of proteins by cationic biopolymers |
| 07/04/1992 | CA2099376A1 Stabilization of proteins by cationic biopolymers |
| 07/02/1992 | DE4038887A1 Verfahren zur herstellung von kollagenpartikeln und ihre verwendung als wirkstofftraeger A process for the production of collagen particles and their use as wirkstofftraeger |
| 07/01/1992 | EP0492930A2 Transdermal delivery of dobutamine |
| 07/01/1992 | EP0492747A2 Pharmaceutical preparation for topical application |
| 07/01/1992 | EP0492707A2 Hydrophilic form of perfluoro compounds and method of manufacture |
| 07/01/1992 | EP0491897A1 Liquid oral pharmaceutical compositions having anti-inflammatory activity |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491858A1 Method and useful apparatus for preparing pharmaceutical compositions |
| 07/01/1992 | EP0491812A1 Drug delivery compositions |
| 07/01/1992 | EP0491754A1 Magnesium carbonate and oil tableting aid |
| 07/01/1992 | EP0362270B1 Steroid lotion |
| 07/01/1992 | EP0308436B1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment |
| 07/01/1992 | EP0256090B1 Solubilization of hydrophobic materials using lysophospholipid |
| 07/01/1992 | EP0179858B1 Antacid composition |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 07/01/1992 | CN1062288A Bioadhesive composition and patch |
| 07/01/1992 | CA2058595A1 Acid-labile linker molecules |
| 06/30/1992 | US5126399 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 06/30/1992 | US5126348 Nicotinic acid as vasodilator |
| 06/30/1992 | US5126333 Mixing with dehydrated cyclodextrin |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/30/1992 | US5126258 Hydrolysis of polypeptides at predetermined site |
| 06/30/1992 | US5126146 Cellulosic coating |